CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Grant or award Director acquired 404 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 569 shares (grant or award)
- 4 Grant or award Director acquired 1,138 shares (grant or award)
Page 17 of 99 · 1,967 filings